get our regular market updates

monthly briefs and insights right to your inbox

Podcast

Biotech Breakouts & the GLP-1 Arms Race: The Drugs That Broke the Market (In a Good Way)

In this episode of Money Talks We Listen, Brian McAree and Richard Croft dive into two of the biggest forces shaping markets today: the biotech boom and rising energy prices. First, they unpack the GLP-1 revolution, exploring how breakthrough weight-loss drugs are transforming healthcare, creating trillion-dollar opportunities, and disrupting everything from food companies to insurance providers. Then they shift to oil’s march toward $100 per barrel, examining how geopolitics, inflation, consumer spending, and Federal Reserve policy are colliding in an increasingly fragile macroeconomic environment.

Podcast

Risk Multiplicity: The Market’s Wall of Worry… and Why It Keeps Climbing It Anyway

In this episode of Money Talks We Listen, Richard Croft and Brian McAree unpack the concept of risk multiplicity and why markets continue to push higher despite a growing list of concerns. From leveraged Treasury trades and AI-driven market concentration to geopolitical tensions, IPO exuberance, and the role of bond vigilantes, they explore the risks investors may be overlooking and how those risks can compound when they occur together.

portfolio managers' brief

Portfolio Managers’ Brief: March 2026

March reinforced the market shift we discussed last month toward greater selectivity, but added a new variable as geopolitical tensions escalated following Operation Epic Fury.

This triggered a spike in oil prices, a shift lower in interest rate expectations, and a short-term increase in market volatility.

Markets pulled back as investors questioned whether this was the start of a broader sell-off or simply temporary volatility.